Capital Market Strategies LLC Has $1.09 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Capital Market Strategies LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 4.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,127 shares of the healthcare conglomerate’s stock after acquiring an additional 100 shares during the period. UnitedHealth Group comprises approximately 1.1% of Capital Market Strategies LLC’s investment portfolio, making the stock its 21st largest holding. Capital Market Strategies LLC’s holdings in UnitedHealth Group were worth $1,092,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth $4,478,185,000. Arrowstreet Capital Limited Partnership boosted its stake in shares of UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after buying an additional 2,540,538 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of UnitedHealth Group by 60.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock worth $2,580,442,000 after purchasing an additional 1,886,128 shares during the period. Capital Research Global Investors raised its holdings in UnitedHealth Group by 8.3% during the 1st quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after acquiring an additional 1,482,338 shares during the period. Finally, Invesco Ltd. increased its holdings in shares of UnitedHealth Group by 28.3% in the first quarter. Invesco Ltd. now owns 6,018,008 shares of the healthcare conglomerate’s stock worth $3,069,002,000 after purchasing an additional 1,328,237 shares during the period. Institutional investors own 87.25% of the company’s stock.

Insider Activity

In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of UnitedHealth Group stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the sale, the executive vice president now directly owns 8,104 shares in the company, valued at approximately $4,043,896. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The disclosure for this sale can be found here. Insiders have sold 140,324 shares of company stock worth $75,086,185 in the last three months. Company insiders own 0.40% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Mizuho upped their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Credit Suisse Group increased their price target on shares of UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. BMO Capital Markets increased their price target on shares of UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. UBS Group increased their price target on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Finally, Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a research note on Wednesday, May 25th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $585.65.

UnitedHealth Group Trading Down 0.4 %

Shares of UNH stock opened at $521.02 on Monday. The firm’s 50 day moving average is $529.29 and its 200 day moving average is $511.81. The stock has a market capitalization of $487.35 billion, a P/E ratio of 27.21, a P/E/G ratio of 1.63 and a beta of 0.76. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company’s revenue was up 12.6% compared to the same quarter last year. During the same quarter last year, the company posted $4.70 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be given a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.27%. UnitedHealth Group’s payout ratio is 34.46%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.